Treatment Persistence and Variations in Prescribing Oral, Injectable, and Inhaled Corticosteroids: A Population‐Based Drug Utilisation Study
A fifth of patients receiving CS accounted for over 80% of oral and inhaled CS prescribing in primary care. Identifying these patients is crucial for targeting future interventions to promote patient safety and cost-effective CS use.
Authors
- Eleni Domzaridou (ORCID: https://orcid.org/0000-0002-0096-1288)
- Darren Mark Ashcroft (ORCID: https://orcid.org/0000-0002-2958-915X)
- Anthony Avery (ORCID: https://orcid.org/0000-0001-7591-4438)
- Tjeerd van Staa (ORCID: https://orcid.org/0000-0001-9363-742X)
- Matthew Carr (ORCID: https://orcid.org/0000-0001-7336-1606)
- Aled Rees (ORCID: https://orcid.org/0000-0002-1165-9092)
- David M. Williams
Institutions
- University of Nottingham (GB)
- Manchester Academic Health Science Centre (GB)
- University of Manchester (GB)
- National Institute for Health and Care Research (GB)
- University of Oxford (GB)
- Cardiff University (GB)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1002/pds.70153
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- Royal College of Physicians